Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 10, 2022

Safety of IV Thrombolysis With Alteplase in Patients With Ischemic Stroke Taking DOACs

Journal of the American Heart Association


Additional Info

Journal of the American Heart Association
Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
J Am Heart Assoc 2022 Sep 21;[EPub Ahead of Print], T Okada, T Yoshimoto, S Wada, S Yoshimura, T Chiba, S Egashira, S Kimura, M Shiozawa, M Inoue, M Ihara, K Toyoda, H Takashima, M Koga

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading